In ₹ Crore except Per Share Latest Annual	RUBICON FY26	SHILPAMED FY26	SPARC FY26	STAR FY26	Peer Average
Valuation — at last close
P/E	100.47×	75.21×	◆ 3.82×	18.19×	32.41× +210%
P/B	19.97×	7.06×	4.43×	◆ 3.26×	4.92× +306%
EV/EBITDA	64.10×	43.51×	◆ 4.06×	12.55×	20.04× +220%
Market Cap	₹25,742 Cr	₹18,300 Cr	₹5,938 Cr	₹10,116 Cr	₹11,451 Cr +125%
Growth
Revenue CAGR 3Y	—	13.59%	◆ 95.98%	9.62%	39.73%
Revenue CAGR 5Y	—	◆ 11.30%	—	7.94%	9.62%
Revenue YoY (latest Q)	—	44.90%	◆ 314.11%	17.11%	125.37%
Net Income YoY (latest Q)	—	◆ 115.16%	59.94%	1.97%	59.02%
Profitability
EBITDA Margin	22.82%	28.25%	◆ 85.08%	19.04%	44.12% -48%
Net Income Margin	14.07%	15.81%	◆ 82.65%	11.82%	36.76% -62%
Return on Common Equity	19.14%	9.80%	◆ 277.35%	19.66%	102.27% -81%
Return on Capital Employed	23.81%	11.47%	◆ 230.55%	19.31%	87.11% -73%
Return on Assets	10.60%	6.94%	◆ 123.94%	8.86%	46.58% -77%
Credit & Quality
Total Debt/Equity	◆ 0.20×	0.25×	0.42×	0.53×	0.40× -50%
Interest Coverage	8.42×	5.36×	◆ 46.54×	4.05×	18.65× -55%
Scale — latest FY
Revenue / Total Income	₹1,754 Cr	₹1,539 Cr	₹1,879 Cr	₹4,859 Cr	₹2,759 Cr -36%
Net Income	₹247 Cr	₹243 Cr	₹1,553 Cr	₹575 Cr	₹790 Cr -69%
Total Assets	₹2,327 Cr	₹3,706 Cr	₹2,171 Cr	₹6,927 Cr	₹4,268 Cr -45%
EPS	₹15.52	₹12.44	₹47.86	₹60.34	₹40.21 -61%
Book Value per Share	₹78.07	₹132.47	₹41.26	₹337.14	₹170.29 -54%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.